Are endobronchial coils appropriate for patients with collateral ventilation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Endobronchial Coils Are Appropriate for Patients with Collateral Ventilation

Yes, endobronchial coils are specifically indicated for patients with collateral ventilation, unlike endobronchial valves which require its absence. This represents a critical distinction in bronchoscopic lung volume reduction therapy selection.

Key Mechanism and Indication

Endobronchial coils work through mechanical re-tensioning of lung parenchyma rather than lobar occlusion, making them independent of collateral ventilation status 1, 2. The GOLD 2017 guidelines acknowledge that lung coils may be considered for bronchoscopic lung volume reduction in selected patients with emphysema and significant hyperinflation refractory to optimized medical care 3.

Patient Selection Algorithm

When collateral ventilation is present:

  • Endobronchial coils are the appropriate bronchoscopic option 2, 4
  • Endobronchial valves are contraindicated (they require absent collateral ventilation) 4, 5

When collateral ventilation is absent:

  • Endobronchial valves are preferred for heterogeneous disease with intact fissures 4, 5
  • Coils remain an alternative option

For homogeneous emphysema distribution:

  • Coils may be considered regardless of collateral ventilation status 2, 4
  • Valves are generally not effective in homogeneous disease

Evidence Base

The GOLD guidelines cite two multicenter trials demonstrating that nitinol coils produced increases in 6-minute-walk distance compared to usual care, with smaller improvements in FEV1 and quality of life (SGRQ) 3. More recent evidence confirms coils can be safely used in collateral ventilation-positive patients, including complex scenarios like native lung hyperinflation after single lung transplantation 6.

Clinical Outcomes

Studies show coils are safe and feasible, with no pneumothorax risk (unlike valves where pneumothorax occurs in ~26% of cases) 7. The therapy improves quality of life and exercise tolerance in appropriately selected patients 2. However, the magnitude of functional improvements may be more modest than with valves in ideal candidates.

Critical Caveat

The presence of collateral ventilation makes coils the only viable bronchoscopic option among established therapies, as valves require complete lobar occlusion to work 4. Emerging alternatives like surgical fissure completion (COVE procedure) or sealants are investigational approaches to enable valve therapy in collateral ventilation-positive patients 8.

Related Questions

What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
In an 81-year-old patient on postoperative day 1 after right intertrochanteric fracture repair, what physical examination should be performed on the right hip and lower extremity?
Does levofloxacin (Levaquin) interact with valproic acid and levetiracetam (Keppra)?
A patient hospitalized for pneumonia improved on IV vancomycin and piperacillin‑tazobactam (Zosyn). What oral antibiotic regimen should be prescribed at discharge to cover typical and atypical pathogens?
What is the optimal oral triple therapy regimen for a patient with glycated hemoglobin (HbA1c) of 12% and random blood glucose (RBG) of 290 mg/dL, and what additional agents should be considered?
Does transcranial magnetic stimulation cause cognitive decline?
How should metformin be combined with an SGLT2 inhibitor and a GLP‑1 receptor agonist in the management of type 2 diabetes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.